Related Experiment Video

Updated: Apr 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K

Measuring tumor metabolism by 18F-FDG PET predicts outcome in a multicenter study: a step off in the right direction

Komal Jhaveri1, Hannah Linden2

  • 1New York University Langone Medical Center New York, New York Komal.Jhaveri@nyumc.org.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|December 25, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K
Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
07:07

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

14.5K

Related Experiment Videos

Last Updated: Apr 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.7K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K
Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
07:07

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

14.5K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

8.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

794
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
794

Articles linked to this work by shared authors, journal, and citation graph.

Axillary Nodal Upstaging in cT1N0 Invasive Lobular Carcinoma: Evaluating Applicability of SOUND Trial Results.

Annals of surgery·2026

ERBB2 Activating Mutations Promote Enhanced Internalization and Activity of Trastuzumab Deruxtecan in HER2-non-amplified Metastatic Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Recurrence risk in HR-positive/HER2-negative early breast cancer: real-world US electronic health records study.

Journal of the National Cancer Institute·2026

Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Concurrent Chemotherapy With Adjuvant Radiation for Patients With High-risk Locally Advanced Breast Cancer: Safety and Outcomes.

Clinical breast cancer·2026

Incidental discovery of second primary lung tumors in breast cancer patients: an institutional case series.

The oncologist·2026

Evaluation of the In Vivo PET Generator 140Nd/140Pr Using a HER2-Targeting Agent.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Fully Automated Segmentation of [18F]FDG and [68Ga]/[18F]PSMA PET/CT Images via Data-Centric Deep Learning.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Head-to-Head Comparison of Neuroblastoma Detection by [64Cu]GD2 PET and [123I]MIBG SPECT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Clinical Imaging of 225Ac in a PET Scanner via Time-of-Flight Cascade γ-Ray Imaging.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Optimizing the Therapeutic Index: Sequential Intraarterial-Intravenous PRRT with Personalized Volumetric-Adjusted Dosing.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Renal Function Decline After 177Lu-PSMA-617 Versus Taxane-Based Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Propensity Score Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Melanoma Recurrence Prediction Using a Tissue-Free Epigenomic Molecular Residual Disease Assay: a Multicenter Prospective Observational Study (COSMOS-MEL01).

Cancer research communications·2026

TCF4-driven cathepsin S promotes papillary thyroid carcinoma via PI3K/AKT/mTOR.

Endocrine-related cancer·2026

Risk factors for subsequent thyroid neoplasms development in childhood cancer survivors.

Endocrine-related cancer·2026

Trends in Location of Death for Individuals with Primary Ocular Cancer in the United States.

Ophthalmic epidemiology·2026

Prognostic Value of Intraoperative Desmopressin Test for Long-Term Remission in Cushing's Disease: A Prospective Cohort Study.

Neurosurgery·2026

Primary Tumor Histologic Regression and Immunotherapy Outcomes in Recurrent or Metastatic Melanoma.

Cancer investigation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us